Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Oxeglitazar, a peroxisome proliferator-activated receptor (PPAR) agonist, is used potentially for the treatment of gout and type two diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 2,120.00 | |
50 mg | 8-10 weeks | $ 2,780.00 | |
100 mg | 8-10 weeks | $ 3,700.00 |
Description | Oxeglitazar, a peroxisome proliferator-activated receptor (PPAR) agonist, is used potentially for the treatment of gout and type two diabetes. |
Synonyms | LM-4156, LM 4156, EMD-336340, EMD336340, EMD 336340 |
Molecular Weight | 314.38 |
Formula | C19H22O4 |
CAS No. | 280585-34-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Oxeglitazar 280585-34-4 LM-4156 LM 4156 EMD-336340 LM4156 EMD336340 EMD 336340 inhibitor inhibit